Options Research

Compare current setups

Put up to five tickers on the same scale. The comparison separates directional pressure, participation, volatility, trend agreement and data quality.

Return to Options Radar

Maximum five tickers. Scores measure evidence alignment, not the probability of a gain.

Strongest evidence alignment LGND 43/100

The highest composite alignment across pressure, participation, trend fit and volatility.

Widest priced move LGND 9.2%

The largest near-term move currently implied by the retained chain.

Strongest participation LGND 18/100

The most active setup relative to open interest and contract-level flow.

Cleanest evidence LGND A · 100/100

The comparison member with the strongest underlying, chain, quote and volatility coverage.

Side-by-side evidence

One scale, comparable inputs

1 current setups
Ticker Read Conviction Pressure Participation Volatility Trend fit Expected move Put-call Volume/OI Evidence
LGNDLigand Pharmaceuticals Incorporated Bearish 43 -38 18 71 59 9.2% 2.50 0.03 A100/100
Bearish

LGND

Ligand Pharmaceuticals Incorporated

43
Priced range 260.99–314.09
Pressure
-38
Participation
18
Trend fit
59
Reference IV
0.49

Options imply 260.99 to 314.09. Max pain at 220.00 lies outside the priced range, so it is a weak near-term anchor.

Open LGND research